FDA inspection
Rohto-Mentholatum (Vietnam) Co., Ltd.: FDA inspection ending Apr 14, 2026
FDA inspection 1312352 · Official Action Indicated (OAI) · Ho Chi Minh
Key facts
| Inspection ID | 1312352 |
|---|---|
| Firm | Rohto-Mentholatum (Vietnam) Co., Ltd. |
| FEI number | 3008808745 |
| Address | No. 16 Vsip, Street No. 5, Vietnam Singapore Industrial Park |
| City | Ho Chi Minh |
| Country | Vietnam |
| Fiscal year | 2026 |
| Inspection end date | Apr 14, 2026 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data